2010
DOI: 10.1001/archophthalmol.2010.110
|View full text |Cite
|
Sign up to set email alerts
|

Successful Topical Application of Caspofungin in the Treatment of Fungal Keratitis Refractory to Voriconazole

Abstract: RESEARCH LETTERSSuccessful Topical Application of Caspofungin in the Treatment of Fungal Keratitis Refractory to Voriconazole F ungal keratitis is an important ophthalmic problem because it leads to corneal blindness and sometimes to loss of the eye. 1,2 There is no agreed protocol for the treatment of suspected fungal keratitis. Topical and oral voriconazole have now been reported to be effective. 3 However, some cases do not respond to this treatment. New antifungal agents such as caspofungin acetate, 0.5%… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
14
0

Year Published

2011
2011
2019
2019

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(14 citation statements)
references
References 5 publications
(6 reference statements)
0
14
0
Order By: Relevance
“…15 Some of the new molecules investigated in recent past include azoles (voriconazole and posaconazole) and eccinocanidines (caspofungin and micafungin). 16,17 While the pharmacological properties, in-vitro susceptibility, as well as the anecdotal reports suggest superiority of voriconazole over other antifungal agents, 16 a randomized clinical trail in South India comparing natamycin with voriconazole in treatment of mycotic keratitis did not find any difference in the scar size, visual acuity, and perforation rate. 18 Therefore, more clinical trials are required to provide rigorous evidence basis to guide using these molecules.…”
Section: Keratitismentioning
confidence: 97%
“…15 Some of the new molecules investigated in recent past include azoles (voriconazole and posaconazole) and eccinocanidines (caspofungin and micafungin). 16,17 While the pharmacological properties, in-vitro susceptibility, as well as the anecdotal reports suggest superiority of voriconazole over other antifungal agents, 16 a randomized clinical trail in South India comparing natamycin with voriconazole in treatment of mycotic keratitis did not find any difference in the scar size, visual acuity, and perforation rate. 18 Therefore, more clinical trials are required to provide rigorous evidence basis to guide using these molecules.…”
Section: Keratitismentioning
confidence: 97%
“…Echinocandins, include caspofungin, micafungin, and anidulafungin. Recently, one case reported by Hurtado-Sarrio et al demonstrated successful treatment of Candida albican keratitis refractory to voriconazole using topical caspofungin [85]. Tu EY reported 3 cases of Alternaria keratitis refractory to voriconazole and natamycin and successful treatment by topical caspofungin and topical fluconazole [86,87].…”
Section: Echinocandinsmentioning
confidence: 99%
“…Clinically, caspofungin is administered mostly intravenously (1,4,6,9,19,20) or intravitreally (24) for ocular mycosis. The successful use of topical caspofungin alone (13) or in combination with voriconazole (22) has been reported for two patients. However, the utility of topical caspofungin in fungal keratitis remains unknown, partly due to limited data on its penetration into human aqueous humor after topical administration.…”
mentioning
confidence: 99%
“…Caspofungin eye drops (0.5%) (11,13,22) were prepared aseptically; 10.5 ml of water for injection was added to a 50-mg vial of caspofungin. All eye drops were freshly prepared and used within 24 h (7).…”
mentioning
confidence: 99%